511 related articles for article (PubMed ID: 28810065)
1. Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis.
Herrmann FE; Wollin L; Wirth J; Gantner F; Lämmle B; Wex E
Br J Pharmacol; 2017 Nov; 174(21):3848-3864. PubMed ID: 28810065
[TBL] [Abstract][Full Text] [Related]
2. The long-acting β2 -adrenoceptor agonist olodaterol attenuates pulmonary inflammation.
Wex E; Kollak I; Duechs MJ; Naline E; Wollin L; Devillier P
Br J Pharmacol; 2015 Jul; 172(14):3537-47. PubMed ID: 25824824
[TBL] [Abstract][Full Text] [Related]
3. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
4. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
5. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium sustains the anti-inflammatory action of olodaterol via the cyclic AMP pathway.
Costa L; Roth M; Miglino N; Keglowich L; Zhong J; Lardinois D; Tamm M; Borger P
Pulm Pharmacol Ther; 2014 Feb; 27(1):29-37. PubMed ID: 24269928
[TBL] [Abstract][Full Text] [Related]
7. Dual inhibition of α
Decaris ML; Schaub JR; Chen C; Cha J; Lee GG; Rexhepaj M; Ho SS; Rao V; Marlow MM; Kotak P; Budi EH; Hooi L; Wu J; Fridlib M; Martin SP; Huang S; Chen M; Muñoz M; Hom TF; Wolters PJ; Desai TJ; Rock F; Leftheris K; Morgans DJ; Lepist EI; Andre P; Lefebvre EA; Turner SM
Respir Res; 2021 Oct; 22(1):265. PubMed ID: 34666752
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls [corrected].
Krempaska K; Barnowski S; Gavini J; Hobi N; Ebener S; Simillion C; Stokes A; Schliep R; Knudsen L; Geiser TK; Funke-Chambour M
Respir Res; 2020 Jan; 21(1):25. PubMed ID: 31941499
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease.
Ichinose M; Takizawa A; Izumoto T; Tadayasu Y; Hamilton AL; Kunz C; Fukuchi Y
Int J Chron Obstruct Pulmon Dis; 2015; 10():1673-83. PubMed ID: 26316741
[TBL] [Abstract][Full Text] [Related]
10. The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts.
Schilter H; Cantemir-Stone CZ; Leksa V; Ohradanova-Repic A; Findlay AD; Deodhar M; Stockinger H; Song X; Molloy M; Marsh CB; Jarolimek W
Immunol Lett; 2015 Jun; 165(2):90-101. PubMed ID: 25929803
[TBL] [Abstract][Full Text] [Related]
11. Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis.
Vittal R; Mickler EA; Fisher AJ; Zhang C; Rothhaar K; Gu H; Brown KM; Emtiazjoo A; Lott JM; Frye SB; Smith GN; Sandusky GE; Cummings OW; Wilkes DS
PLoS One; 2013; 8(10):e76451. PubMed ID: 24204629
[TBL] [Abstract][Full Text] [Related]
12. Autophagy and the unfolded protein response promote profibrotic effects of TGF-β
Ghavami S; Yeganeh B; Zeki AA; Shojaei S; Kenyon NJ; Ott S; Samali A; Patterson J; Alizadeh J; Moghadam AR; Dixon IMC; Unruh H; Knight DA; Post M; Klonisch T; Halayko AJ
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L493-L504. PubMed ID: 29074489
[TBL] [Abstract][Full Text] [Related]
13. Endogenous Semaphorin-7A Impedes Human Lung Fibroblast Differentiation.
Esnault S; Torr EE; Bernau K; Johansson MW; Kelly EA; Sandbo N; Jarjour NN
PLoS One; 2017; 12(1):e0170207. PubMed ID: 28095470
[TBL] [Abstract][Full Text] [Related]
14. Combined Activation of Guanylate Cyclase and Cyclic AMP in Lung Fibroblasts as a Novel Therapeutic Concept for Lung Fibrosis.
Lambers C; Boehm PM; Karabacak Y; Samaha E; Benazzo A; Jaksch P; Roth M
Biomed Res Int; 2019; 2019():1345402. PubMed ID: 30984775
[TBL] [Abstract][Full Text] [Related]
15. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
16. Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol.
Casarosa P; Kollak I; Kiechle T; Ostermann A; Schnapp A; Kiesling R; Pieper M; Sieger P; Gantner F
J Pharmacol Exp Ther; 2011 Jun; 337(3):600-9. PubMed ID: 21357659
[TBL] [Abstract][Full Text] [Related]
17. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
18. Amplified canonical transforming growth factor-β signalling
Sibinska Z; Tian X; Korfei M; Kojonazarov B; Kolb JS; Klepetko W; Kosanovic D; Wygrecka M; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Guenther A; Schermuly RT
Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28182573
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y
Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302
[TBL] [Abstract][Full Text] [Related]
20. Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts.
Wyman AE; Noor Z; Fishelevich R; Lockatell V; Shah NG; Todd NW; Atamas SP
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L945-L958. PubMed ID: 28385812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
